BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2184131)

  • 1. Experimental gastric and duodenal ulcers. Advances in pathogenesis.
    Szabo S; Vattay P
    Gastroenterol Clin North Am; 1990 Mar; 19(1):67-85. PubMed ID: 2184131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental basis for a role for sulfhydryls and dopamine in ulcerogenesis: a primer for cytoprotection--organoprotection.
    Szabo S
    Klin Wochenschr; 1986; 64 Suppl 7():116-22. PubMed ID: 3560772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements.
    Brzozowski T
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():99-126. PubMed ID: 15075467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the pathogenesis of primary and secondary stomach ulcers].
    Mosin VI; Ermolaeva NIu; Pasechnikov VD
    Ter Arkh; 1988; 60(2):11-5. PubMed ID: 3368852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis, diagnosis and treatment of acute gastric mucosal lesions.
    Marrone GC; Silen W
    Clin Gastroenterol; 1984 May; 13(2):635-50. PubMed ID: 6430609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Specific IgE in the gastric and duodenal mucosa. An epiphenomenon or pathogenetic mechanism of some forms of "peptic" ulcer?].
    De Lazzari F; Venturi C; Fregona I; Galliani EA; Bortolami M; Violato D; Floreani AR; Plebani M; Naccarato R
    Minerva Gastroenterol Dietol; 1994 Mar; 40(1):1-9. PubMed ID: 8204699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
    Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
    Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of centrally administered losartan on gastric and duodenal ulcers in rats.
    Merai AH; Asad M; Prasad VS
    Pharmacology; 2009; 84(2):93-8. PubMed ID: 19602912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dopamine-related drugs on duodenal ulcer induced by cysteamine or propionitrile: prevention and aggravation may not be mediated by gastrointestinal secretory changes in the rat.
    Gallagher G; Brown A; Szabo S
    J Pharmacol Exp Ther; 1987 Mar; 240(3):883-9. PubMed ID: 3559980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of centrally administered oxytocin on gastric and duodenal ulcers in rats.
    Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
    Acta Pharmacol Sin; 2001 Jun; 22(6):488-92. PubMed ID: 11747752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity.
    Brzozowski T; Konturek SJ; Kwiecien S; Pajdo R; Drozdowicz D; Sliwowski Z; Muramatsu M
    J Physiol Pharmacol; 1998 Mar; 49(1):83-98. PubMed ID: 9594413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of local secretory and motility changes in the pathogenesis of experimental duodenal ulcer.
    Szabo S; Pihan G; Gallagher GT; Brown A
    Scand J Gastroenterol Suppl; 1984; 92():106-11. PubMed ID: 6588493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contact transendoscopic thermometry via a tube in active gastric and duodenal ulcer].
    Tenev T
    Vutr Boles; 1982; 21(3):21-5. PubMed ID: 7113182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects.
    Stoltz RR; Harris SI; Kuss ME; LeComte D; Talwalker S; Dhadda S; Hubbard RC
    Am J Gastroenterol; 2002 Jan; 97(1):65-71. PubMed ID: 11808971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental studies on the pathophysiology of peptic ulcer disease.
    Pfeiffer CJ
    Scand J Gastroenterol Suppl; 1982; 72():19-25. PubMed ID: 6753113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current views on pathogenesis of peptic ulcer.
    Baron JH
    Scand J Gastroenterol Suppl; 1982; 80():1-10. PubMed ID: 6819636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiology of the harmful influence of smoking on the course of gastric and duodenal ulcer diseases].
    BudzyƄski J; Swiatkowski M
    Przegl Lek; 1996; 53(11):811-5. PubMed ID: 9173445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
    Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
    Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of methanolic extract of Pongamia pinnata Linn seed on gastro-duodenal ulceration and mucosal offensive and defensive factors in rats.
    Prabha T; Dorababu M; Goel S; Agarwal PK; Singh A; Joshi VK; Goel RK
    Indian J Exp Biol; 2009 Aug; 47(8):649-59. PubMed ID: 19775071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.